Targeting Vascular Destruction by Sonosensitizer‐Free Sonocatalytic Nanomissiles Instigates Thrombus Aggregation and Nutrition Deprivation to Starve Pancreatic Cancer

Abstract Sonosensitizers in current sonodynamic therapy (SDT) often suffer from poor delivery efficiency, phototoxicity, and disputed safety. To overcome these issues, a sonosensitizers‐free sonocatalytic nanomissile is constructed, wherein PLGA nanoparticles as vehicles conjugate with L‐arginine (LA) and aptamer XQ2d capable of adsorbing CO 2 and targeting CD71‐overexpressed pancreatic cancer, respectively. The adsorbed CO 2 can respond to acidic tumor microenvironment and local ultrasound to release CO 2 bubbles and enhance ultrasound‐triggered inertial cavitation, which can further split H 2 O and activate dissolved O 2 to produce ·OH and 1 O 2 , respectively, unlocking the sonosensitizers‐free sonocatalytic ROS birth. Moreover, such CO 2 bubbles‐enhanced inertial cavitation also can target intratumoral vascular destruction, instigate thrombus aggregation, induce nutrition and oxygen deprivation, pose hypoxia and alter tumor metabolism, thus establishing an intratumoral vascular destruction‐targeted starvation therapy. The strategy is different from previous starvation therapy in which the presence of undamaged intratumoral blood vessels compromises their outcomes. Especially, the active targeting aptamer XQ2d allows more sonosensitizer‐free sonocatalytic nanomissiles to retain in pancreatic cancer, significantly magnifying the sonosensitizers‐free sonocatalytic therapy and starvation therapy against subcutaneous and orthotopic pancreatic cancers. Therefore, the research provides a promising route and therapeutic platform for clinical pancreatic cancer therapy.